Our in vitro experiments have shown that limiting AKR1D1 expression and activity regulates fundamental metabolic processes within human hepatoma cells that govern hepatic insulin sensitivity, lipid accumulation and carbohydrate metabolism. The gene discussed is AKR1D1; the disease is hepatocellular carcinoma.